Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × codrituzumab × Clear all

NCT00976170 2014-10-03

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular